Sun Pharma adds $1.6m sterile manufacturing line in Guwahati, India

By Flora Southey contact

- Last updated on GMT

(Image: Getty/dk_photos)
(Image: Getty/dk_photos)

Related tags: Sun pharma, India

Sun Pharma has installed a parenteral drug production line in Guwahati for the manufacture of sterile products.

According to the firm, the Rs 120 crores ($1.6m) investment will enhance Sun Pharma’s capacity to manufacture lyophilized vials, liquid ampoules, and eye drops at the 14-acre Guwahati site.

Located in India’s eastern state of Assam, the Guwahati facility also houses granulation, tablet compression, and capsule filling capabilities.

Sun Pharma’s managing director, Dilip Shanghvi, said this latest investment responds to a governmental push for increased industrial activities and employment opportunities in Assam.

“Sun Pharma is committed to the government’s ‘Make in India’ initiative,” ​Shanghvi told delegates at the production line launch.

“In the next few years, the Guwahati plant is expected to become of the largest facilities in our network to manufacture sterile products,” ​he added.

Despite manufacturing setbacks in Gujarat​ and Halol​ earlier in the year, Sun Pharma recently announced regulatory success in the US for two separate drug products.

In August, the firm launched​ its extended-release Kapspargo Sprinkle drug product for the treatment of hypertension, angina pectoris or heart failure.

The following month, Sun Pharma announced​ its eye disease treatment, Cequa (cyclosporine ophthalmic solution) had received US Food and Drug Administration approval. 

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us

Products

View more

Webinars